Staged margin control techniques for surgical excision of lentigo maligna

Giornale Italiano di Dermatologia e Venereologia

Volumn 144, Issue 3, 2009, Pages 259-270

  Raziano, R M ^a   Clark, G S ^b   Cherpelis, B S ^a,c   Sondak, V K ^c   Cruse, C W ^c   Fenske, N A ^a,c   Glass, L F ^a,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Melanoma, etiology; Melanoma, surgery; Mohs surgery, methods; Skin neoplasms, etiology; Skin neoplasms, surgery; Treatment outcome

Indexed keywords

MELAN A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROTEIN S 100;

CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FOLLOW UP; FROZEN SECTION; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT LENTIGO; MELANOCYTE; PEROPERATIVE CARE; REVIEW; SKIN DEFECT; SURGICAL TECHNIQUE; TISSUE SECTION;

EID: 68849095244     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Hutchinson J. Lentigo-melanosis. Arch Surg 1894;5:253-255
2. Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 1995;33:923-36; quiz 37-40.
3. Clark WH Jr, Elder DE, Van Horn M. The biologic forms of malignant melanoma. Hum Pathol 1986;17:443-450
4. McKenna JK, Florell SR, Goldman GD, Bowen GM. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol Surg 2006;32:493-504.
5. National Institutes of Health Consensus Development Conference Statement on Diagnosis and Treatment of Early Melanoma, January 27-29, 1992. Am J Dermatopathol 1993;15:34-43; discussion 6-51.
6. Sober AJ, Chuang TY, Duvic M, Farmer ER, Grichnik JM, Halpern AC et al. Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol 2001;45:579-586 (Pubitemid 32917254)
7. National Comprehensive Cancer Network clinical practice guidelines in oncology:melanoma. Jenkintown, PA: 2007 [cited 2007 September 1, 2007]. Available from: http://www.nccn.org/professionals/physician-gls/PDF/melanoma. pdf.
8. Bricca GM, Brodland DG, Ren D, Zitelli JA. Cutaneous head and neck melanoma treated with Mohs micrographic surgery. J Am Acad Dermatol 2005;52:92-100. (Pubitemid 40038940)
9. Huilgol SC Selva D, Chen C, Hill DC, James CL, Gramp A et al. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision. Arch Dermatol 2004; 140:1087-1092 (Pubitemid 39223116)
10. Albertini JG, Elston DM, Libow LF, Smith SB, Farley MF. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Dermatol Surg 2002;28:656-665
11. Zalla MJ, Lim KK, Dicaudo DJ, Gagnot MM. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg 2000:26:771-784
12. Agarwal-Antal N, Bowen GM, Gerwels JW. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J Am Acad Dermatol 2002;47:743-748 (Pubitemid 35239337)
13. Moller MG, Pappas-Politis E, Zager JS, Santiago LA, Yu D, Prakash A et al. Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol 2009;16:1526-1536
14. Jejurikar SS, Borschel GH, Johnson TM, Lowe L, Brown DL. Immediate, optimal reconstruction of facial lentigo maligna and melanoma following total peripheral margin control. Plast Reconstr Surg 2007;120:1249-1255 (Pubitemid 47493947)
15. Anderson KW, Baker SR, Lowe L, Su L, Johnson TM. Treatment of head and neck melanoma, lentigo maligna subtype: a practical surgical technique. Arch Facial Plast Surg 2001;3:202-206
16. Johnson TM, Headington JT, Baker SR, Lowe L. Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: the "square" procedure. J Am Acad Dermatol 1997;37:758-764
17. Mahoney MH, Joseph M, Temple CL. The perimeter technique for lentigo maligna: an alternative to Mohs micrographic surgery. J Surg Oncol 2005;91:120-125 (Pubitemid 41077053)
18. Cohen LM, McCall MW, Zax RH. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. A follow-up study. Dermatol Surg 1998;24:673-677 (Pubitemid 28294414)
19. Bub JL, Berg D, Slee A, Odland PB. Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up. Arch Dermatol 2004;140:552-558 (Pubitemid 38668962)
20. Walling HW, Scupham RK, Bean AK, Ceilley RI. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 2007;57:659-664 (Pubitemid 47393585)
21. Malhotra R, Chen C, Huilgol SC, Hill DC, Selva D. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma. Ophthalmology 2003;110:2011-2018 (Pubitemid 37163323)
22. Hill DC, Gramp AA. Surgical treatment of lentigo maligna and lentigo maligna melanoma. Australas J Dermatol 1999;40:25-30. (Pubitemid 29128087)
23. Temple CL, Ariette JP. Mohs micrographic surgery in the treatment of lentigo maligna and melanoma. J Surg Oncol 2006;94:287-292 (Pubitemid 44330851)
24. Bhardwaj SS, Tope WD, Lee PK. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience. Dermatol Surg 2006;32:690-6; discussion 6-7.
25. Bienert TN, Trotter MJ, Ariette JP. Treatment of cutaneous melanoma of the face by Mohs micrographic surgery. J Cutan Med Surg 2003;7:25-30. (Pubitemid 36350855)
26. Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol 1997;37:236-245 (Pubitemid 27355710)
27. Zitelli JA, Brown CD, Hanusa BH. Surgical margins for excision of primary cutaneous melanoma. J Am Acad Dermatol 1997;37:422-429 (Pubitemid 27430641)
28. Bene NI, Healy C, Coldiron BM. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases. Dermatol Surg 2008;34:660-664 (Pubitemid 351569486)
29. Dawn ME, Dawn AG, Miller SJ. Mohs surgery for the treatment of melanoma in situ: a review. Dermatol Surg 2007;33:395-402. (Pubitemid 46570109)
30. Mohs FE. Chemosurgery: a microscopically controlled method of cancer excision. Arch Surg 1941;42:279-295
31. Shriner DL, McCoy DK, Goldberg DJ, Wagner RF Jr. Mohs micrographic surgery. J Am Acad Dermatol 1998;39:79-97.
32. Dhawan SS, Wolf DJ, Rabinovitz HS, Poulos E. Lentigo maligna. The use of rush permanent sections in therapy. Arch Dermatol 1990;126:928-930
33. Clayton BD, Leshin B, Hitchcock MG, Marks M, White WL. Utility of rush paraffin-embedded tangential sections in the management of cutaneous neoplasms. Dermatol Surg 2000;26:671-678 (Pubitemid 30470633)
34. Cohen LM, McCall MW, Hodge SJ, Freedman JD, Callen JP, Zax RH. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections. Cancer 1994;73:2964-2970
35. Zitelli JA, Moy RL, Abell E. The reliability of frozen sections in the evaluation of surgical margins for melanoma. J Am Acad Dermatol 1991;24:102-106
36. Barlow RJ, White CR, Swanson NA. Mohs' micrographic surgery using frozen sections alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ. BrJ Dermatol 2002;146:290-294
37. Barlow JO, Maize J Sr, Lang PG. The density and distribution of melanocytes adjacent to melanoma and nonmelanoma skin cancers. Dermatol Surg 2007;33:199-207.
38. Weyers W, Bonczkowitz M, Weyers I, Bittinger A, Schill WB. Melanoma in situ versus melanocyte hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis. Am J Dermatopathol 1996;18:560-566 (Pubitemid 27020167)
39. Acker SM, Nicholson JH, Rust PF, Maize JC. Morphometric discrimination of melanoma in situ of sun-damaged skin from chronically sun-damaged skin. J Am Acad Dermatol 1998;39:239-245
40. Hendi A, Brodland DG, Zitelli JA. Melanocytes in long-standing sunexposed skin: quantitative analysis using the MART-I immunostain. Arch Dermatol 2006;142:871-876 (Pubitemid 44079787)
41. Florell SR, Boucher KM, Leachman SA, Azmi F, Harris RM, Malone JC et al. Histopathologic recognition of involved margins of lentigo maligna excised by staged excision: an interobserver comparison study. Arch Dermatol 2003;139:595-604. (Pubitemid 36576375)
42. Bricca GM, Brodland DG, Zitelli JA. Immunostaining melanoma frozen sections: the 1-hour protocol. Dermatol Surg 2004;30:403-408
43. Kelley LC, Starkus L. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-I. J Am Acad Dermatol 2002;46:78-84. (Pubitemid 34073482)
44. Davis DA, Kurtz KA, Robinson RA. Ultrarapid staining for cutaneous melanoma: study and protocol. Dermatol Surg 2O05;31:753-6; discussion 6.
45. PrietoVG, Argenyi ZB, Barnhill RL, Duray PH, Elenitsas R, From L et al. Are en face frozen sections accurate for diagnosing margin status in melanocyte lesions? Am J Clin Pathol 2003;120:203-208
46. El Shabrawi-Caelen L, Kerl H, Cerroni L. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis. Am J Dermatopathol 2004;26: 364-366 (Pubitemid 39287355)
47. Wiltz KL, Qureshi H, Patterson JW, Mayes DC, Wick MR. Immunostaining for MART-I in the interpretation of problematic intra-epidermal pigmented lesions. J Cutan Pathol 2007;34:601-605
48. Helm K, Hndeis-Hosey J. Immunohistochemistry of pigmented actinic keratoses, actinic keratoses, melanomas in situ and solar lentigines with Melan-A. J Cutan Pathol 2008;35:931-934
49. Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW. Immunohisto-chemical characteristics of melanoma. J Cutan Pathol 2008;35:433-444
50. King R, Weilbaecher KN, McGill G, Cooley E, Mihm M, Fisher DE. Microphthalmia transcription factor, a sensitive and specific melanocyte marker for melanoma diagnosis. Am J Pathol 1999;155:731-738 (Pubitemid 29426819)
51. Kimyai-Asadi A, Ayala GB, Goldberg LH, Vujevich J, Jih MH. The 20-minute rapid MART-I immunostain for malignant melanoma frozen sections. Dermatol Surg 2008;34:498-500.
52. Cherpelis BS, Moore R, Ladd S, Chen R, Glass LF. Comparison of MART-I frozen sections to permanent sections using a rapid 19- minute protocol. Dermatol Surg 2009;35:207-213
53. Calder K, Higgins H, Clark GS, Cherpelis BS, Ladd S, Glass LF. Rapid frozen tissue immunostaining of melanocytes by microophthalmic transcription factor. J Cutan Pathol 2009;36:180.